Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Brand Murray Fuller opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Brand Murray Fuller

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3889181Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJan 24, 2025BRAND MURRAY FULLER
EP2662094Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025BRAND MURRAY FULLER
EP3529360Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 16, 2025INTAS PHARMACEUTICALS
EP3150200Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 10, 2025BRAND MURRAY FULLER
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024ACCORD HEALTHCARE
EP4159204Novel Pharmaceutical CompositionNOVARTISNov 14, 2024BRAND MURRAY FULLER
EP4159205Novel Pharmaceutical CompositionNOVARTISNov 14, 2024BRAND MURRAY FULLER
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 7, 2024BRAND MURRAY FULLER
EP3286270Coating Composition Including Alkyl OximesADVANSIX RESINS & CHEMICALSOct 24, 2024TROY CHEMICAL
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 17, 2024BRAND MURRAY FULLER SERVICES